Across TCGA pan-cancer cohorts, MIR323A RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR323A data layer compared with 3 for mutation status.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR323A RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR323A expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

STAD, BRCA, and LAML are the cancer types where MIR323A RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.471	0.669	.004	54	view →
BRCA	OS	Tertile	III,IV	0.027	0.907	<.001	36	view →
LAML	DFS	Tertile	All	0.831	0.331	.005	30	view →
ACC	DFS	Tertile	All	0.048	0.623	<.001	27	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR323A tumor-vs-normal RNA expression · all MIR323A data types